Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015: cancer statistics in China, 2015. CA A Cancer J Clin. 2016;266:115–32.
Zhang S, Sun K, Zheng R, Zeng H, Wang S, Chen R, et al. Cancer incidence and mortality in China, 2015. J Natl Cancer Center. 2021;1:2–11.
Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014;69:640–9.
Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14:392–7.
Shamliyan T, Talley KMC, Ramakrishnan R, Kane RL. Association of frailty with survival: a systematic literature review. Ageing Res Rev. 2013;12:719–36.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381:752–62.
Mohile SG, Magnuson A, Pandya C, Velarde C, Duberstein P, Hurria A, et al. community oncologists’ decision-making for treatment of older patients with cancer. J Natl Compr Canc Netw. 2018;16:301–9.
Ethun CG, Bilen MA, Jani AB, Maithel SK, Ogan K, Master VA. Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin. 2017;67:362–77.
Aaldriks AA, van der Geest LGM, Giltay EJ, le Cessie S, Portielje JEA, Tanis BC, et al. Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol. 2013;4:218–26.
Neuman HB, Weiss JM, Leverson G, O’Connor ES, Greenblatt DY, Loconte NK, et al. Predictors of short-term postoperative survival after elective colectomy in colon cancer patients ≥ 80 years of age. Ann Surg Oncol. 2013;20:1427–35.
Puts MTE, Monette J, Girre V, Pepe C, Monette M, Assouline S, et al. Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. Crit Rev Oncol Hematol. 2011;78:138–49.
Basch E, Abernethy AP, Mullins CD, Reeve BB, Smith ML, Coons SJ, et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol. 2012;30:4249–55.
Costa DSJ, Mercieca-Bebber R, Rutherford C, Tait M-A, King MT. How is quality of life defined and assessed in published research? Qual Life Res. 2021;30:2109–21.
Geessink N, Schoon Y, van Goor H, Olde Rikkert M, Melis R. TOPICS-MDS consortium. Frailty and quality of life among older people with and without a cancer diagnosis: findings from TOPICS-MDS. PLoS One. 2017;12:48.
de Vries J, Bras L, Sidorenkov G, Festen S, Steenbakkers RJHM, Langendijk JA, et al. Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer. Oral Oncol. 2020;111:105020–105020.
Karimi M, Brazier J. Health, health-related quality of life, and quality of life: What is the difference? Pharmacoeconomics. 2016;34:645–9.
Kanesvaran R, Wang W, Yang Y, Wei Z, Jia L, Li F, et al. Characteristics and treatment options of elderly Chinese patients with cancer as determined by comprehensive geriatric assessment (CGA). J Geriatric Oncol. 2014;5:171–8.
Chen F, Pang Y, Mao N, Luo J, Cai D. Current status of frailty and depression and its correlation study in elderly patients with lung cancer. Nurs Pract Res. 2020;17:9–12.
Wang K, Chen C, Li S. Reliability and validity of chinese version of comprehensive frailty assessment instrument. Chin J Rehabilit Theory Pract. 2017;23:72–6.
Pottel L, Boterberg T, Pottel H, Goethals L, Van den Noortgate N, Duprez F, et al. Determination of an adequate screening tool for identification of vulnerable elderly head and neck cancer patients treated with radio(chemo)therapy. J Geriatr Oncol. 2012;3:24–32.
Petit-Monéger A, Rainfray M, Soubeyran P, Bellera CA, Mathoulin-Pélissier S. Detection of frailty in elderly cancer patients: Improvement of the G8 screening test. J Geriatr Oncol. 2016;7:99–107.
Kim SH, Kim HJ, Lee S-I, Jo M-W. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Qual Life Res. 2012;21:1065–73.
Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.
Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20:662–9.
Lin K-C, Cheng S-F. Tobit model for outcome variable is limited by censoring in nursing research. Nurs Res. 2011;60:354–60.
Kim MJ, Park S, Jung Y, Kim S-H, Oh I-H. Exploring health-related quality of life and frailty in older adults based on the Korean frailty and aging cohort study. Qual Life Res. 2020;29:2911–9.
Yang Z, Busschbach J, Liu G, Luo N. EQ-5D-5L norms for the urban Chinese population in China. Health Qual Life Outcomes. 2018;16:210.
Loh KP, Ramdass S, McHugh C, Mohile SG, Maggiore RJ. Assessing frailty and vulnerability in older adults with cancer. Curr Geri Rep. 2017;6:231–8.
Baitar A, Van Fraeyenhove F, Vandebroek A, De Droogh E, Galdermans D, Mebis J, et al. Evaluation of the groningen frailty indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer. J Geriatr Oncol. 2013;4:32–8.
Soubeyran P, Bellera C, Goyard J, Heitz D, Cure H, Rousselot H, et al. Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study. PLoS ONE. 2014;9: e115060.
Quinten C, Kenis C, Decoster L, Debruyne PR, De Groof I, Focan C, et al. Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery. Qual Life Res. 2019;28:663–76.
Hamaya T, Hatakeyama S, Momota M, Narita T, Iwamura H, Kojima Y, et al. Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study). Int J Clin Oncol. 2020;26:199–206.
de Mello Ramirez Medina J, de Araujo Trugilho I, Mendes GNB, Silva JG, da Silva Paiva MA, de Aguiar SS, et al. Advanced clinical stage at diagnosis of breast cancer is asssociated with poorer health-related quality of life: a cross-sectional study. Eur J Breast Health. 2019;15:26–31.
Rosenfeld B, Roth AJ, Gandhi S, Penson D. Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psychooncology. 2004;13:800–7.
Gong N, Du Q, Lou H, Zhang Y, Fang H, Zhang X, et al. Treatment decision-making for older adults with cancer: a qualitative study. Nurs Ethics. 2021;28:242–52.
Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60:1487–92.
Lee SJ, Son H, Shin SK. Influence of frailty on health-related quality of life in pre-dialysis patients with chronic kidney disease in Korea: a cross-sectional study. Health Qual Life Outcomes. 2015;13:70.
留言 (0)